ITERUM THERAPEUTICS PLC

ITRM NASDAQ
6.76
+0.06
+0.90%
已收盘, 16:00 08/16 EDT
开盘
6.71
昨收
6.70
最高
6.88
最低
6.71
成交量
3,402
成交均量(3M)
8,272
52周最高
11.22
52周最低
4.700
换手率
0.03%
市值
8,884.50万
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供ITERUM THERAPEUTICS PLC ITRM股票价格,ITERUM THERAPEUTICS PLC股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Iterum Therapeutics PLC is a clinical-stage pharmaceutical company. The Company is focused on developing significantly differentiated anti-infectives aimed at combatting the global crisis of multi-drug resistant (MDR) pathogens. The Company is developing sulopenem - the oral and intervenous (IV) penem antibiotic demonstrating a potent spectrum of activity against multi-drug resistant gram-negative. It is a bioavailable, antibiotic covering gram-positive, gram-negative and anaerobic pathogen with in-vitro activity against multidrug-resistant pathogens, including Extended-Spectrum Beta-Lactamase (ESBL)-producing Escherichia, coli and Klebsiella and pneumonia. It has demonstrated potent in vitro activity against all genera of Enterobacteriacease, in anaerobes such as Bacteroides, Prevotella, Porphyromonas, Fusobacterium and Peptostreptococcus, gram-positive organisms including methicillin-susceptible staphylococci, Streptococcus pyogenes and Streptococcus pneumonia.
展开 >

最近浏览

名称
价格
涨跌幅